anthonyyazdaniml/gliner-biomed-balanced-curated-corpus huggingface dataset:
The invention provides a processing technology of honey-making rehmannia root, which adopts low-temperature and vacuum mode. Concretely, the invention has the following steps: a. the medicament of raw material. b. the preliminary processing of fresh rehmannia root. c. the medicament of sugar liquor and the immersion of rehmannia root. d. the medicament of the rehmannia root and honey. e. drying and packing. The invention basically keeps the original nutritional components of the rehmannia root and the honey, meanwhile, the invention   improves taste of the rehmannia root, the honey-making rehmannia root which is made has the following effects: &lt;1&gt; heat-clearing, nourishing Yin, body fluid regenerating, blood nourishing, blood cooling, blood pressure lowering, and heart rate decreasing. &lt;2&gt; the invention can inhibit little liquid in stool, duodenal ulcer, conjunctivitis, and child cold-dysentery and the like. &lt;3&gt; the invention has a certain curative effects to insomnia and headache. &lt;4&gt; the invention has certain functions to infected wound, burn, and frost-injury. &lt;5&gt; the invention has the function of beauty.
&lt;P&gt;PROBLEM TO BE SOLVED: To provide a clinical examination report forming system capable of simply displaying a clinical examination report.  &lt;P&gt;SOLUTION: When patient data such as the name, age (receiving date, etc.), or the like of a patient is inputted from a keyboard (40) and the image data of the clinical examination result of the specimen sampled from the patient is inputted from a CCD camera, the respective data are registered on a data base (21). These data are displayed on a display (50) according to display layout data (22). When comment data is inputted by an examiner observing this display screen, it is displayed on the display (50) to be registered on the data base (21).  &lt;P&gt;COPYRIGHT: (C)2003,JPO
&lt;P&gt;PROBLEM TO BE SOLVED: To provide a skin-lightening cosmetic exhibiting excellent bleaching effects and originated from a natural product.  &lt;P&gt;SOLUTION: Arenaria kansuensis Maxim. is a perennial small herb mainly distributed in China such as Tibet, Gansu, Qinghai and the western part of Sichuan, and grows in a crack of a stone in a high mountain of limestone or in meadow. The bleaching cosmetic is obtained by newly discovering that an extract of the Arenaria kansuensis Maxim. has melanin formation-inhibiting effects, and the cosmetic formulated with the Arenaria kansuensis Maxim. has the excellent bleaching effects although there is an example of the extract of the Arenaria kansuensis Maxim. formulated in an external preparation for the skin as a humectant.  &lt;P&gt;COPYRIGHT: (C)2009,JPO&amp;INPIT
&lt;P&gt;PROBLEM TO BE SOLVED: To provide a mixed herb using Rubus idaeus, that is, a mixed herb formulated with a herb for adjusting the sense of taste of the Rubus idaeus to favorably adjust the sense of taste, and to provide a herb tea adjusted in sense of taste obtained from the mixed herb.  &lt;P&gt;SOLUTION: The mixed herb comprises powdery Rubus idaeus and a powdery herb for adjusting the sense of taste in the weight ratio of preferably (1:1) to (5:1). In this mixed herb, the powdery Rubus idaeus, hard to disperse, are approximately the same in particle size as the powdery herb for adjusting the sense of taste through grinding by a specific method, being favorably usable for maternity. The herb tea is obtained by extraction from the mixed herb. The mixed herb and the herb tea can be taken in well-balanced manner in the sense of taste through mixing the Rubus idaeus with the herb for adjusting the sense of taste such as Rosa canina. This mixed herb is suitable for pregnant women of 24 week after pregnancy for maternity use.  &lt;P&gt;COPYRIGHT: (C)2005,JPO&amp;NCIPI
&lt;P&gt;PROBLEM TO BE SOLVED: To provide a gene construct, etc., useful for gene therapy for treating muscle-affecting diseases, including cardiovascular disorders.  &lt;P&gt;SOLUTION: This present invention concerns chimeric constructs comprising a skeletal α-actin gene promoter operably linked with at least a skeletal muscle- specific enhancer of a human gene. It also provides an expression cassette comprising such a chimeric construct to control expression of a gene of interest. The invention also relates to a vector, a viral particle, an eukaryotic host cell, a pharmaceutical composition each comprising the expression cassette and their use for specific expression in skeletal muscle cells as well as for therapeutic or prophylactic purposes. Finally, the present invention also provides the therapeutic use of an expression cassette, a vector and a viral particle comprising a gene of interest placed under the control of a skeletal α-actin gene promoter and a muscle-specific enhancer, especially for treating peripheral ischemia.  &lt;P&gt;COPYRIGHT: (C)2003,JPO
&lt;P&gt;PROBLEM TO BE SOLVED: To provide 3, 5-dihydroxy-2-menthenyl stilbene, to provide a plant extract containing the same, to provide an antimicroorganism agent, and to provide a method for collecting the extract, and to provide applications of the extract.  &lt;P&gt;SOLUTION: A new compound, 3, 5-dihydroxy-2-menthenyl stilbene represented by structural formula (1), is provided. A genus Lindera plant extract containing 1 mass% or more of the same is also provided. Applications of antimicroorganism agents or the like each with the extract as an active ingredient are provided. Besides, a method for collecting the active ingredient of a genus Lindera plant is provided. A mixture of the compound of formula (1) and 3, 5-dihydroxystilbene is also provided. A genus Lindera plant extract containing 1 mass% or more of the mixture is provided. Further, applications of offensive odor production inhibitors or the like each with the above extract as an active ingredient are provided.  &lt;P&gt;COPYRIGHT: (C)2011,JPO&amp;INPIT
CAY-1 is a fungicidal saponin from the cayenne pepper ( Capsicum frutescens ) fruit. The saponins 1081 and 919, closely elute with, and are close structural relatives of, CAY-1. Saponin 1081 is poorly antifungal while 919 has no antifungal properties. Nongerminated and germinating conidia of  Aspergilus flavus, A. fumigatus, A. niger, Fusarium oxysporum, F. solani , and  F. verticilioides  were tested against pure CAY-1 and CAY-1:1081:919 at ratios of 8:1:1, 6:2:2 and 4:3:3 and efficacy was determined after various incubation times. Pure CAY-1 and all saponin mixtures were significantly (p&lt;0.001) lethal to the germinating conidia of  A. flavus, A. niger , and  F. solani . All saponin mixtures were equal or superior to pure CAY-1 in antifungal properties. Mixtures of the naturally occurring inactive or poorly fungicidal saponins with reduced levels of CAY-1 display superior fungicidal properties when compared to pure CAY-1 at the same dose levels.
An ocular biometer utilizing a light emitting source and corresponding optics to illuminate areas of the eye in order to analyze the wavefront of the reflected light. Aperture sharing elements, such as &#34;hot mirrors&#34; are used to allow the eyes to view the world, was the ocular biometer measures various characteristics of the eye such as the refractive (i.e., accommodative) state, the gaze angle and the pupil diameter at any instant of time and continuously. Optical wavefront conditioning and wavefront sensing techniques are used to determine the refractive power of the eye and the instantaneous accommodative state. Reflected light is projected through a reticle or plurality of reticles. Spatial characteristics of the resulting shadow pattern uniquely determine the characteristics of the eye. These shadow patterns can be measured directly or by causing a modulation of the lines with a second identical reticle placed appropriately between the first and the imaging plane. The bright pupil and a Purkinje image may be used to compute the gaze angle (or, line-of-sight).
FIELD: medicine. ^ SUBSTANCE: invention refers to biotechnology. The vaccine contains an active substance and target additives. The active substance is presented with mixed inactivated suspensions of cattle infectious rhinotracheitis virus strain, SVC (State Virus Collection) No. 2333, Herpesviridae family, Alphaherpesviridae subfamily, inactivated suspension of cattle diarrhoea virus strain SVC No. 2336, Flaviviridae family, Pestivirus genus, inactivated suspension of cattle rotavirus strain, SVC No. 2337, Reoviridae family, Rotavirus genus, inactivated suspension of cattle coronavirus strain, SVC No. 2338, Coronaviridae family, Coronavirus genus with activity of each virus strain not less than 106.5 &#34;ö&#34;50 per 1 cm3 of the vaccine. As said active substance, the vaccine also contains mixed inactivated suspension of Leptospira interrogans bacteria cells of Pomona serogroup of strain VGNKI-6, inactivated suspension of Leptospira interrogans bacteria cells of Tarassovi serogroup of strain VGNKI-4, inactivated suspension of Leptospira interrogans bacteria cells of Grippotyphosa serogroup of strain VGNKI-1, inactivated suspension of Leptospira interrogans bacteria cells of Sejroe serogroup of Hardjo strain and inaktivirovannoj suspensions of cells of bacteria Leptospira interrogans of Sejroe serogroup of strain VGNKI-5 taken in the ratio equal to final concentration of each Leptospira strain not less than 270 million microbial cells per 1 cm3 of the vaccine. The vaccine is intended for prevention of cattle infectious diseases accompanied by reproductive disorders of various severities. ^ EFFECT: vaccine is better than common vaccines in the spectrum of specific protection and effectiveness for tolerant group of animals, duration of intense immunity, harmlessness for incalvers and newborn calves, stability of biological properties, including antigen and immunogen activity throughout 18 months (follow-up period). ^ 3 cl, 10 tbl, 6 ex
1376136 Hair curling L&#39;OREAL 11 Nov 1971 [12 Nov 1970] 52433/71 Heading A4V [Also in Divisions A5, H3-5] A process for the treatment of fibres e.g. artificial fibres or human hair, comprises placing them in a cavity resonator formed by a curling iron, curler or hair drying hood which has been matched both to the generator and to the transmission line from the generator. As shown in Fig. 2 a hair curler comprises a two part separable casing one part of which consists of a perforated metal end wall 4 secured to an insulating cylinder 3 on which hair 12 is wound and the other part of which consists of perforated metal cylinder 6 and perforated end wall 7. In this embodiment matching is achieved by a coupling component 10 in the form of a coil which is connected to the central conductor and outer screen of a coaxial cable 13. The natural frequency of the casing resonator formed by the two part casing is reduced to correspond to that of the generator by means of a helical conductor 9 wound on cylinder 3 and secured at one end 9b only to the casing. Alternatively coil 9 need not be connected to the casing or it may be connected at one or more spaced points. In Fig. 3 (not shown) the matching coupling is in the form of rectilinear conductor connected to the central conductor of the coaxial cable. In Fig. 4 (not shown) the matching coupling is in the form of an antenna connected to the core of the coaxial cable. To compensate for the decrease in dielectric loss factor of hair as it dries a cylinder of a material whose dielectric loss factor and constant increase with temperature is provided around insulating cylinder 3. In Fig. 6 (not shown) the device is in the form of a curling iron, the conductive envelope comprising two pivoted half shells which may be opened and closed by means of levers. In Figs. 8, 9, 10 (not shown) the device comprises a central core which forms the coupling component, a roller on which the hair is wound and which can optionally incorporate frequency matching means and a two part pivoted conductive shell. The coupling component comprises two coils connected to the central conductor of the coaxial cable and via a by-pass condenser to earth. Various chemical and heat treatment processes are described in detail.
&lt;P&gt;PROBLEM TO BE SOLVED: To provide a dried gel material which improves swallowing of an oral medicine and suitable for masking the oral medicine having an unpleasant flavor, to provide the oral medicine comprising the dried material, and to provide an inexpensive and simple method for preparing the medicine.  &lt;P&gt;SOLUTION: The dried gel material is prepared by drying a gel-like material prepared by mixing a positively chargeable polyelectrolyte with a negatively chargeable polyelectrolyte. The mixture comprises the dried material and an active ingredient of the medicine or an additive of the medicine. The oral medicine is prepared from the mixture. The method for preparing the oral medicine comprises mixing the positively chargeable polyelectrolyte with the negatively chargeable polyelectrolyte and the active ingredient of the medicine or the additive of the medicine, affording the gel-like material and drying the resultant gel-like material or mixing the positively chargeable polyelectrolyte with the negatively chargeable polyelectrolyte, affording the gel-like material, drying the gel-like material, adding a solution or a suspension of the active ingredient of the medicine or a solution or a suspension of the additive of the medicine to the dried gel material, carrying out swelling and gelation and drying the gel.  &lt;P&gt;COPYRIGHT: (C)2009,JPO&amp;INPIT
1,144,875. Guanidine derivatives. PHILIPS&#39; GLOEILAMPENFABRIEKEN N.V. 7 March, 1966 [10 March, 1965], No. 9888/66. Heading C2C. The invention comprises compounds of formula wherein R 1  and R 2  are hydrogen atoms or C 1-12  alkyl, aryl, aryloxyalkyl or aralkyl groups, which may be substituted by one or more halogen atoms or alkyl or alkoxy groups, or R 1  and R 2  together with the carbon atom to which they are attached form a C 4-14  saturated or unsaturated alicyclic group which may be substituted by one or more alkyl or aryl groups and/or may have one or two further alicyclic or aromatic rings condensed therewith, acid addition salts thereof, and their preparation by (a) reaction of a compound of formula or an acid addition salt thereof with cyanamide or with a compound of formula wherein X is a group easily replaced by an amino group, (b) reaction of a compound of formula R 1 R 2 C=NOH or a salt thereof with a compound of formula wherein X is a reactive ester group, (c) reaction of a compound of formula wherein Y is a halogen atom or a tosyloxy group, with guanidine or (d) reaction of a compound of formula R 1 COR 2  with 0-(2-guanidinoethyl)-hydroxylamine. Compounds of formula are prepared by reaction of a compound of formula R 1 R 2 C=NOH with aziridine or with a 2-halo- or 2-tosyloxy-ethylamine. The compounds of the invention have antihypertensive activity and may be used in pharmaceutical compositions in combination with a carrier for example in forms suitable for oral, parenteral or rectal administration.
A Chinese medicinal composition for treating hyperlipidemia. At present, hypolipidemic drugs are generally adopted for treating hyperlipidemia, but some adverse reactions are easily caused. If etofibrate is used, upper abdominal fullness, pruritus and the like can be caused. The technical scheme of the invention is as follows: soaking processed rhizoma cyperi, costustoot, combined spicebush root, orange peel, green tangerine peel, immature bitter orange, officinal magnolia bark, villous amomum fruit, round cardamom, nardostachyos root-bark, citron bark, danshen root, szechuan lovage rhizome, peach seed, safflower, hiraute shiny bugleweed herb, turmeric root tuber, yanhusuo, trogopterus dung, frankincense, myrrh, lignum dalbergiae odoriferae, astragalus root, largehead atractylodes rhizome, manyflower solomonseal rhizome, cotton root, bidens tripartita, hawthorn, medicated leaven, malt, rice sprout, chicken&#39;s gizzard-membrane, rhubarb and raw liquorice in 1300 ml of water for 30 minutes, then decocting with slow fire, and filtering the decocted liquid. It has the advantages that: the medicine has stable therapeutic effect and is not easy to rebound. Meanwhile, the side effects caused by some existing medicines are avoided.
Set forth herein are garnet material compositions, e.g., lithium-stuffed garnets and lithium-stuffed garnets doped with alumina, which are suitable for use as electrolytes and catholytes in solid state battery applications. Also set forth herein are lithium-stuffed garnet thin films having fine grains therein. Disclosed herein are novel and inventive methods of making and using lithium-stuffed garnets as catholytes, electrolytes and/or anolytes for all solid state lithium rechargeable batteries. Also disclosed herein are novel electrochemical devices which incorporate these garnet catholytes, electrolytes and/or anolytes. Also set forth herein are methods for preparing novel structures, including dense thin (&lt;50um) free standing membranes of an ionically conducting material for use as a catholyte, electrolyte, and, or, anolyte, in an electrochemical device, a battery component (positive or negative electrode materials), or a complete solid state electrochemical energy storage device. Also, the methods set forth herein disclose novel sintering techniques,  e.g ., for heating and/or field assisted (FAST) sintering, for solid state energy storage devices and the components thereof.
The complete nucleotide sequence of a proviral molecular clone of the lymphadenopathy-associated virus, LAV, was ascertained. Recombinant phage clones were isolated from a genomic library of LAV-infected human T-lymphocyte DNA. The insert of recombinant phase  lambda J19 was sequenced according to the dideoxy chain termination method. In addition to the retroviral structural genes gag, pol, and env, a novel open reading frame (ORF) was identified in the 3&#39; region of the viral genome and designated ORF-R. The ORF-R coding region, which has subsequently been renamed nef, encodes a 206 amino acid protein that slightly overlaps the 3&#39; end of the env gene and the 5&#39; portion of the U3 region of the viral long terminal repeat (LTR). Nucleic acids encoding this protein and the precise amino acid sequence of the Nef are disclosed in this application. These products are useful for the generation of immunological reagents to facilitate the detection of LAV.
A system and application for providing a user with interactive and individualized assistance in selecting an appropriate product for the user based on one or more user-selected goals is provided. The consumer or user accesses the application over a computer network such as the Internet and selects items for purchase from a database. The graphical interface can organize the products, for example, by a pre-selected value, a product category, or the consumer&#39;s historical shopping data. The application then reviews the selected products or items and recommends substitutions to help the consumer achieve specified goals. The application also includes additional functionality to permit the consumer to shop on a collection of products basis, e.g. a per-recipe basis for grocery items or a per-outfit basis for fashion or clothing items, to access to current in-store promotions of products or items, and to receive automated notification of promotions that are personalized to the consumer, for example, using historical shopping data or specified goals.
PURPOSE:To obtain the subject compound having skin-beautifying action and useful as an active component of a skin-beautifying external drug such as face lotion and pack at a low cost by extracting root sheath of mulberry with a water-containing hydrophilic organic solvent. CONSTITUTION:The objective compound can be produced by extracting root sheath of mulberry with a water-containing hydrophilic organic solvent. Concretely, the root sheath of mulberry is crushed and cut into small pieces and extracted with a mixture of water and a hydrophilic organic solvent such as methanol. The ratio of the organic solvent in the extraction solvent is &gt;=50%, preferably about 70-95%. About 5-15 pts. of the extraction solvent is added to 1 pt. of the root sheath and heated under refluxing or left to rest at normal temperature or under heating. The solvent is distilled off from the obtained extracted liquid and the residue is dissolved in about 10-100 times volume of water. The solution is passed through a column packed with a synthetic polymer adsorbent having a macro-network structure to obtain the objective compound.
The invention on hand refers to diseases associated with abnormal protein structures, including Alzheimer&#39;s disease, Creutzfeldt-Jakob&#39;s disease, BSE and other prion-associated diseases. It is the task of the invention on hand to provide new active agents preventing the formation of amyloid plaques and to dissolve existing plaques, such agents being convenient for therapy, diagnosis and prophylaxis of diseases that are associated with abnormal protein structures. This task is performed in terms of the current invention by heterocyclic or aromatic agents with a rigid structure and a donor-acceptor-donor pattern (DAD), the latter being formed by donors and acceptors of hydrogen bridge linkages which comply with the β-sheet structure of the peptide or protein and thus fit as binding partners. The heterocyclic or aromatic agents are available at least as dimers. They recognise peptides and proteins with a β-sheet structure, form stable complexes with them and inhibit their aggregation to β-amyloid plaques. Furthermore, the new active agents are able to dissolve β-amyloid plaques that already exist. Another task of the current invention is to provide methods for the synthesis of said heterocyclic or aromatic compounds.
The cooperative learning method is structured on students\&amp;#39; communication and interaction with each other. Many outcomes such as increasing students; academic success, critical thinking, verbal communication, taking responsibility for learning, improving their ability to take responsibility, increasing their ability to evaluate, and being open to feedback are among the benefits of cooperative learning. In cooperative learning, the basic principle is that students form groups and share their knowledge within each group regarding the basic knowledge and skills they want to learn, and then the groups interact with each other. With this method, students can take on learning responsibilities themselves, and they can also develop their knowledge sharing, collaboration and leadership skills within the group. Therefore, cooperative learning is an effective training method by strengthening self-directed learning, as well as supporting effective communication within team members. In a study conducted with nursing students using cooperative learning, it was observed that higher success, more positive relationships between students, and more psychological adaptation developed compared to traditional education methods. In international studies investigating the use of active learning strategies in nursing education, it has been concluded that collaborative learning is of great importance in transforming critical thinking ability, clinical performance, knowledge adequacy and nursing knowledge into clinical skills. In a similar vein, it has been emphasized that cooperative learning is an effective teaching method in improving the knowledge and psychomotor skill levels of nursing students regarding local drug applications and increasing the permanence of information. This study will focus on students; learning of knowledge and skills regarding enteral nutrition through cooperative learning method. A more memorable learning is aimed by students forming groups and transferring information both within and between groups.